Search by property
Appearance
This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.
List of results
- Inglis et al. (2020): Effects of High-Dose Vitamin D Supplementation on Phase Angle and Physical Function in Patients with Prostate Cancer on ADT + (Androgen deprivation therapy)
- Zalat et al. (2020): Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy + (Anthracycline-chemotherapy, chemotherapy regime: AC: Adriamycin + cyclophosphamide, FAC: 5-flourouracil + Adriamycin +cyclophosphamide, CHOP: Cyclophosphamide + Adriamycin + Oncovin +Prednisone)
- Niravath et al. (2019): Randomized controlled trial of high‐dose versus standard‐dose vitamin D3 for prevention of aromatase inhibitor‐induced arthralgia + (Aromatase inhibitor therapy)
- Kraft et al. (2012): L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial + (At entry 88% of patients in the placebo and 92% of patients in the L-Carnitine group received chemotherapy.)
- Raoufinejad et al. (2019): Oral calcitriol in hematopoietic recovery and survival after autologous stem cell transplantation: a randomized clinical trial + (Autologous peripheral blood hematopoietic stem cell transplantation)
- Stendell-Hollis et al. (2010): Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors + (Breast cancer survivors; completed primary … Breast cancer survivors; completed primary treatment(s) for invasive, early stage breast cancer at least 12 months prior and no more than 10 years prior; received chemotherapy (neo-adjuvant or adjuvant with any medically-prescribed agent/regime) for treatmentlly-prescribed agent/regime) for treatment)
- Ribeiro et al. (2017): Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer + (CAPOX (capecitabine + oxaliplatin) schedule; capecitabine; 5-fluorouracil and folinic acid)
- Uthaipaisanwong et al. (2020): Effects of ginger adjunct to the standard prophylaxis on reducing carboplatin and paclitaxel-induced nausea vomiting: a randomized controlled study + (Carboplatin-paclitaxel chemotherapy Types of chemotherapy, n (%) neoadjuvant: 4 (8.5), adjuvant: 43 (91.5))
- Hoopfer et al. (2015): Three-arm randomized phase III trial: Quality aloe and placebo cream versus powder as skin treatment during breast cancer radiation therapy + (Chemotherapy before radiotherapy per arm … Chemotherapy before radiotherapy per arm</br></br>Powder arm: No = 47 (59.5%); Yes = 32 (40.5%)</br></br>Aloe arm: No = 31 (38.3%); Yes = 50 (61.7%)</br></br>Placebo arm: No = 36 (46.8%); Yes = 41 (53.3%)</br></br></br>Surgery per arm: </br></br>Powder arm: Mastectomy = 32 (40.5%); Segmental resection = 47 (59.5%)</br></br>Aloe arm: Mastectomy = 34 (42%); Segmental resection = 47 (58%)</br></br>Placebo arm: Mastectomy = 23 (29.9%); Segmental resection = 54 (70.1%) (29.9%); Segmental resection = 54 (70.1%))
- Wyatt et al. (2017): A Randomized Clinical Trial of Caregiver-Delivered Reflexology for Symptom Management During Breast Cancer Treatment + (Chemotherapy or specific cancer therapy: 210 patients, hormone therapy only: 46 patients.)
- Strasser et al. (2006): Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled (…) + (Chemotherapy patients (received chemotherapy in the 4 weeks before baseline and who intended to continue chemotherapy during the study), per arm: THC = 52% Cannabis extract = 47% Placebo = 52%)
- Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue + (Chemotherapy per arm (n): Aloe vera arm: yes = 24; no = 83 Placebo arm: yes = 24; no = 77)
- Braga et al. (2015): Effect of Zinc Supplementation on Serological Response to Vaccination Against Streptococcus Pneumoniae in Patients Undergoing Chemotherapy for Colorectal Cancer + (Chemotherapy regimen: CAPOX (capecitabine + oxaliplatin), Capecitabine or 5-fluorouracil + folinic acid)
- Ansari et al. (2016): Efficacy of Ginger in Control of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients Receiving Doxorubicin- Based Chemotherapy + (Chemotherapy regimens (n intervention vs. … Chemotherapy regimens (n intervention vs. placebo arm):</br></br>- AC, i.e. doxorubicin60 mg/m2 +cyclophosphamid 600 mg/m<sup>2</sup> (41 vs. 44)</br></br>- CAF, i.e. cyclophosphamide 500mg/m2 + doxorubicin 50mg/ m<sup>2</sup> + 5-Fluorouracil 500mg/m<sup>2</sup> (19 vs. 18)</br></br>- TAC, i.e. docetaxel 75mg/m<sup>2</sup> + doxorubicin 50mg/m<sup>2</sup> + cyclophosphamide 500mg/m<sup>2</sup> (15 vs. 13)up> + doxorubicin 50mg/m<sup>2</sup> + cyclophosphamide 500mg/m<sup>2</sup> (15 vs. 13))
- Arbabi-kalati et al. (2012): Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: A double-blind randomized clinical trial + (Chemotherapy treatment by a regimen including cyclophosphamide, doxorubicin, dacarbazine, gemcitabine, methotrexate, and 5-fluorouracil)
- Arslan et al. (2015): Oral Intake of Ginger for Chemotherapy-Induced Nausea and Vomiting Among Women With Breast Cancer + (Chemotherapy with adjuvant anthracycline (chemotherapy protocols: anthracycline, cyclophosphamide, doxorubicin, and 5-fluorouracil), no significant differences between arms in chemotherapy characteristics (p > 0.05))
- Braik et al. (2014): Randomized trial of vitamin B6 for preventing hand-foot syndrome from capecitabine chemotherapy + (Chemotherapy with capecitabine Capecitabine alone (n = 43) Capecitabine + oxaliplatin (n = 24) Capecitabine + lapatinib (n = 5) Capecitabine + trastuzumab (n = 3) Capecitabine + cetuximab (n = 2))
- Olsen et al. (2001): The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy + (Chemotherapy: Aloe arm: Yes = 28%, No = 72% Control arm: Yes = 26%, No = 74% Cumulative dose was dichotomized into ≤2,700 cGy or >2,700 cGy.)
- Lissoni et al. (2009): A Randomized Study of Chemotherapy versus Biochemotherapy with Chemotherapy plus Aloe arborescens in Patients with Metastatic Cancer + (Chemotherapy: Non-small cell lung cancer … Chemotherapy: </br></br>Non-small cell lung cancer: Chemotherapy consisted of cisplatin (CDDP) plus etoposide (VP16) or weekly vinorelbine (VNR)</br></br>Small cell lung cancer: Chemotherapy consisted of cisplatin (CDDP) plus etoposide (VP16)</br></br>Colorectal cancer: low-dose oxaliplatin (OXA) plus 5-fluorouracil (5-FU)</br></br>Gastric cancer: weekly 5-fluorouracil </br></br>Pancreatic adenocarcinoma: weekly gemcitabine (GEM)c adenocarcinoma: weekly gemcitabine (GEM))
- Stephenson et al. (2017): Partner-delivered reflexology: Effects on cancer pain and anxiety. + (Chemptherapy/Radiation therapy/OP (at least 6 weeks before or after surgery))
- Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study + (Cisplatin)
- Fahimi et al. (2011): Evaluating the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens + (Cisplatin chemotherapy regimens, n (%) * … Cisplatin chemotherapy regimens, n (%) </br>* Cisplatin + Etoposide 7 (19%)</br></br>* Cisplatin + Gemcitabine 7 (19%)</br></br>* Cisplatin + Docetaxel 11 (31%)</br></br>* Cisplatin + Vinorelbine 4 (11%)</br></br>* Cisplatin + Cyclophosphamide + Doxorubicin 4 (11%)</br></br>* Cisplatin + Paclitaxel + Doxorubicin 1 (3%)</br></br>* Cisplatin + 5-FU + Docetaxel 1 (3%)</br></br>* Cisplatin + Pemetrexed 1 (3%)el 1 (3%) * Cisplatin + Pemetrexed 1 (3%))
- Argyriou et al. (2006): A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final results + (Cisplatin-based chemotherapy)
- Li et al. (2018): Efficacy of Ginger in Ameliorating Acute and Delayed Chemotherapy-Induced Nausea and Vomiting Among Patients With Lung Cancer Receiving Cisplatin-Based Regimens: A Randomized Controlled Trial + (Cisplatin-based chemotherapy (few patients with carboplatin or oxaliplatin))
- Pace et al. (2010): Vitamin E neuroprotection for cisplatin neuropathy + (Cisplatin-based chemotherapy, cisplatin was administered in combination regimens on the basis of the specific tumor site)
- Pace et al. (2003): Neuroprotective Effect of Vitamin E Supplementation in Patient Treated With Cisplatin Chemotherapy + (Cisplatin-based chemotherapy; Cisplatin w … Cisplatin-based chemotherapy;</br></br>Cisplatin was administered in combination regimens based on the specific tumor site as follows: </br>Lung and urethral cancer:cisplatin 75 mg/m² on day 1 and gemcitabine 1,000 mg/m² on day 1 and day 8 every 3 weeks; ovarian cancer: cisplatin 75 mg/m² and endoxan 600 mg/m² on day 1 every 3 weeks; head and neck cancer: cisplatin 100 mg/m² on day 1 and fluorouracil 1,000 mg/m² on day 1 to 4 every 3 to 4 weeks; ethmoidal cancer: cisplatin 25 mg/m² and etoposide 80 mg/m² on day 1 to 3 every 3 weeks; gastric cancer: PELF regimen (cisplatin 40 mg/m² and epirubicin 30 mg/m² on days 1 and 5 plus fluorouracil 300 mg/m² and folinic acid 100 mg/m² on days 1 to 4 every 3 weeks); testicular cancer: PEB regimen (cisplatin 20 mg/m² and etoposide 100 mg/m² on days 1 to 5 plus bleomycin 30 mg on days 2, 9, and 16 every 3 weeks) 30 mg on days 2, 9, and 16 every 3 weeks))
- Mahmoodnia et al. (2017): Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients + (Cisplatin-chemotherapy)
- Villani et al. (2016): Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial + (Cisplatin-chemotherapy)